Glucose represses connexin36 in insulin-secreting cells
Author:
Allagnat Florent1, Martin David1, Condorelli Daniele F.2, Waeber Gérard1, Haefliger Jacques-Antoine1
Affiliation:
1. Department of Internal Medicine, Laboratory of Molecular Biology 19-135S, University Hospital, CHUV-1011 Lausanne, Switzerland 2. Department of Chemical Sciences, University of Catania, 95125 Catania, Italy
Abstract
The gap-junction protein connexin36 (Cx36) contributes to control the functions of insulin-producing cells. In this study, we investigated whether the expression of Cx36 is regulated by glucose in insulin-producing cells. Glucose caused a significant reduction of Cx36 in insulin-secreting cell lines and freshly isolated pancreatic rat islets. This decrease appeared at the mRNA and the protein levels in a dose- and time-dependent manner. 2-Deoxyglucose partially reproduced the effect of glucose, whereas glucosamine, 3-O-methyl-D-glucose and leucine were ineffective. Moreover, KCl-induced depolarization of β-cells had no effect on Cx36 expression, indicating that glucose metabolism and ATP production are not mandatory for glucose-induced Cx36 downregulation. Forskolin mimicked the repression of Cx36 by glucose. Glucose or forskolin effects on Cx36 expression were not suppressed by the L-type Ca2+-channel blocker nifedipine but were fully blunted by the cAMP-dependent protein kinase (PKA) inhibitor H89. A 4 kb fragment of the human Cx36 promoter was identified and sequenced. Reporter-gene activity driven by various Cx36 promoter fragments indicated that Cx36 repression requires the presence of a highly conserved cAMP responsive element (CRE). Electrophoretic-mobility-shift assays revealed that, in the presence of a high glucose concentration, the binding activity of the repressor CRE-modulator 1 (CREM-1) is enhanced. Taken together, these data provide evidence that glucose represses the expression of Cx36 through the cAMP-PKA pathway, which activates a member of the CRE binding protein family.
Publisher
The Company of Biologists
Reference54 articles.
1. Abderrahmani, A., Steinmann, M., Plaisance, V., Niederhauser, G., Haefliger, J. A., Mooser, V., Bonny, C., Nicod, P. and Waeber, G. (2001). The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1). Mol. Cell Biol.21, 7256-7267. 2. Arnette, D., Gibson, T. B., Lawrence, M. C., January, B., Khoo, S., McGlynn, K., Vanderbilt, C. A. and Cobb, M. H. (2003). Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J. Biol. Chem.278, 32517-32525. 3. Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P. A. and Wollheim, C. B. (1992). Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology130, 167-178. 4. Belluardo, N., Trovato-Salinaro, A., Mudo, G., Hurd, Y. L. and Condorelli, D. F. (1999). Structure, chromosomal localization, and brain expression of human CX36 gene. J. Neurosci. Res.57, 740-752. 5. Briaud, I., Lingohr, M. K., Dickson, L. M., Wrede, C. E. and Rhodes, C. J. (2003). Differential activation mechanisms of ERK-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes52, 974-983.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|